Breast cancer research at Providence Cancer Center

May 27, 2016

Providence Cancer Center is currently enrolling patients in more than 20 studies investigating a broad spectrum of breast cancer therapies and interventions. We offer studies aimed at improving cure rates, quality of life and survival for both early-stage and metastatic breast cancer patients.

Providence participates in a variety of study types, from small phase I clinical trials to larger international studies, including offerings from the National Cancer Institute, our own NCI Community Oncology Research Program (the Pacific Cancer Research Consortium), and pharmaceutical industry partners. Our own investigator-initiated studies, available exclusively at Providence Cancer Center, focus on novel approaches that harness the immune system to treat cancer.

A team of breast cancer specialists
The research team at the Earle A. Chiles Research Institute at Providence Cancer Center includes oncologists who specialize exclusively in breast cancer, as well as breast-cancer-focused research nurses, laboratory scientists, data coordinators and lab assistants. Every person on this team is passionate about providing the best possible care and the best available study options for patients with breast cancer.

More than 20 breast cancer studies currently open
Our current breast cancer studies focus on providing immunotherapies, targeted therapies and other agents across the care continuum, including:

  • Neoadjuvant
  • Surgical
  • Adjuvant
  • Endocrine
  • Metastatic
  • Cancer control
  • Quality of life

New studies are added frequently. For a complete list of all current studies at Providence Cancer Center, including phase I, II and III clinical trials, please visit our website. For more information, call 503-215-2614.